Skip to main content
VCbacked
Log inGet Started

Think Bioscience

Boulder, United States

Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.

$55.0M raised
Jan 2026
Series A
BiotechnologyLife ScienceTherapeutics

Top Investors

T.A. SpringerNational Science FoundationJanus Henderson InvestorsAV8 VenturesInnovation Endeavors

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Think Bioscience

How much funding has Think Bioscience raised?
Think Bioscience has raised $55.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Who are Think Bioscience's investors?
Think Bioscience's investors include T.A. Springer, National Science Foundation, Janus Henderson Investors, AV8 Ventures, Innovation Endeavors.
Where is Think Bioscience headquartered?
Think Bioscience is headquartered in Boulder, United States.
What does Think Bioscience do?
Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.
What stage is Think Bioscience at?
Think Bioscience is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Think Bioscience — Funding & Investors." VCBacked, January 20, 2026, https://www.vcbacked.co/company/think-bioscience. Accessed June 3, 2026.
APA
VCBacked. (2026). Think Bioscience — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/think-bioscience
Wikipedia (cite web)
{{cite web |title=Think Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/think-bioscience |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong